Yıl: 2015 Cilt: 26 Sayı: 6 Sayfa Aralığı: 456 - 460 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection

Öz:
Background/Aims: In our study, we aimed to assess the effect of vitamin E and C supplementation to triple and quadruple Helicobacter pylori eradication regimens. Materials and Methods: Four hundred patients with H. pylori infection were classified into four groups. Patients in group A (n=100) received amoxicillin, clarithromycin, and lansoprazole for 2 weeks. In group B, patients (n=100) received vitamins C and E for a month, in addition to amoxicillin, clarithromycin, and lansoprazole for 2 weeks. Patients in group C (n=100) received amoxicillin, clarithromycin, lansoprazole, and bismuth subcitrate for 2 weeks, whereas those in group D (n=100) received vitamins C and E for a month, in addition to amoxicillin, clarithromycin, lansoprazole, and bismuth subcitrate for 2 weeks. H. pylori eradication was assessed with the C14 urea breath test 2 months after the end of the therapy. The eradication rate was assessed using per-protocol (PP) and intention-to-treat (ITT) analyses. Results: Three hundred forty-eight patients finished the study. The eradication of H. pylori was achieved in 63 of 84 patients (75%) by PP and 63 of 100 (63%) by ITT analysis in group A, 60 of 84 (71.4%) by PP and 60 of 100 (60%) by ITT analysis in group B, 72 of 89 (80.9 %) by PP and 72 of 100 (72%) by ITT analysis in group C, and 76 of 91 (83.5%) by PP and 76 of 100 (76%) by ITT analysis in group D. There was no remarkable change between groups A and B (p>0.05). Similar results were also found between groups D and C (p>0.05).Conclusion: This study revealed that supplementing vitamins C and E to either the triple or quadruple therapies did not provide an additional advantage for achieving significantly higher eradication rates for H. pylori
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Barik A. Salih Helicobacter pylori Infection in Developing Countries: The Burden for How Long? Saudi J Gastroenterol 2009; 15: 201-7. [CrossRef]
  • 2. Goodman K, Correa P. The Transmission of Helicobacter pylori. A Critical Review of the Evidence. Int J Epidemiol 1995; 24: 875-87. [CrossRef]
  • 3. Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002; 70: 1984-90. [CrossRef]
  • 4. Niknam R, Seddigh M, Fattahi MR, Dehghanian A, Mahmoudi L. Prevalence of Helicobacter pylori in Patients With Dyspepsia. Jundishapur J Microbiol 2014; 7: e12676. [CrossRef]
  • 5. Ferwana M, Abdulmajeed I, Alhajiahmed A, et al. Accuracy of urea breath test in Helicobacter pylori infection: Meta-analysis. World J Gastroenterol. 2015; 21: 1305-14. [CrossRef]
  • 6. Oluwasola AO. Genetic determinants and clinico-pathological outcomes of helicobacter pylori infection. Ann Ib Postgrad Med 2014; 12: 22-30.
  • 7. Dzieniszewski J, Jarosz M. Guidelines in the medical treatment of Helicobacter pylori infection. J Physiol Pharmacol 2006; 57 Suppl 3: 143-54.
  • 8. Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81. [CrossRef]
  • 9. Sasaki M, Ogasawara N, Utsumi K, et al. Changes in 12-Year FirstLine Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin. J Clin Biochem Nutr 2010; 47: 53-8. [CrossRef]
  • 10. Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. Helicobacter 2003; 8: 95-104. [CrossRef
  • 11. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006; 28: 1960-6. [CrossRef]
  • 12. Aydin A, Onder GF, Akarca US, Tekin F, Tunçyürek M, Musoglu A. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycin-resistant and sensitive cases. Turk J Gastroenterol 2005; 16: 203-6.
  • 13. Chey WD, Wong BCY. American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. Am J Gastroenterol 2007; 102: 1808. [CrossRef]
  • 14. Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and metaanalysis of sequentialtherapy. BMJ 2013; 347: f4587. [CrossRef]
  • 15. Sezikli M, Cetinkaya ZA, Sezikli H, et al. Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? Helicobacter 2009; 14: 280-5. [CrossRef]
  • 16. Sezikli M, Çetinkaya ZA, Güzelbulut F, et al. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. J Clin Pharm Ther 2012; 37: 282-5. [CrossRef]
  • 17. Sjunnesson H, Sturegård E, Willén R, Wadström T. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp Med 2001; 51: 418- 23.
  • 18. Sun YQ, Girgensone I, Leanderson P, et al. Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2005; 10: 33-42. [CrossRef]
  • 19. Zhang ZW, Patchett SE, Perrett D, et al. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998; 43: 322-6. [CrossRef]
  • 21. Laheij RJ1, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection--a metaanalysis. Aliment Pharmacol Ther 1999; 13: 857-64. [CrossRef]
  • 22. Gao W, Cheng H, Hu F, et al. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter 2010; 15: 460-6. [CrossRef]
  • 23. De Francesco V, Giorgio F, Hassan C, et al. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010; 19: 409-14.
  • 24. Jarosz M, Rychlik E, Siuba M, et al. Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J Gastroenterol. 2009 Mar 7; 15: 1119-25. [CrossRef]
  • 25. Egan BJ, Katicic M, Connor HJO, Morain CAO. Treatment of Helicobacter pylori. Helicobacter 2007; 12: 31-7. [CrossRef]
  • 26. Amidou Samie, Nicoline F. Tanih , Roland N. Ndip (2014). Helicobacter pylori Infection — Challenges of Antimicrobial Chemotherapy and Emergence of Alternative Treatments, Trends in Helicobacter pylori Infection, Dr. Bruna Roesler (Ed.), ISBN: 978-953-51-1239-6, InTech, Available from: http://www.intechopen.com/books/trends-in-helicobacter-pylori-infection/ helicobacter-pylori-infection-challenges-of-antimicrobial-chemotherapy-and-emergence-of-alternative-
  • 27. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002; 1: 323-36. [CrossRef]
  • 28. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Alimentary Pharmacology and Therapeutics 1999; 13: 13-8. [CrossRef]
  • 29. De Falco M, Lucariello A, Iaquinto S, Esposito V, Guerra G, De Luca A. Molecular Mechanisms of Helicobacter Pylori Pathogenesis. J Cell Physiol 2015; 29.
  • 30. Buommino E, Donnarumma G, Manente L, et al. The Helicobacter pylori protein HspB interferes with Nrf2/Keap1 pathway altering the antioxidant response of Ags cells. Helicobacter 17; 2012: 417‐25. [CrossRef]
  • 31. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin-C concentrations in plasma, gastric juice, and gastrointestinal mucosa: Effect of gastritis and oral supplementation. Gut 1996; 38: 171-6. [CrossRef]
  • 32. Simon JA, Hudes ES, Perez-Perez GI. Relation of Serum Ascorbic Acid to Helicobacter pylori Serology in US Adults: The Third National Health and Nutrition Examination Survey. J Am Coll Nutr 2003; 22: 283-9. [CrossRef]
  • 33. Pal J, Sanal MG, Gopal GJ. Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review. Indian J Pharmacol 2011; 43: 624-7.
  • 34. Ma E, Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Tsugane S. Vitamin C supplementation in relation to inflammation in individuals with atrophic gastritis: a randomised controlled trial in Japan. Br J Nutr 2013; 109: 1089-95. [CrossRef]
  • 35. Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J Infect Dis 1996; 173: 1502-5. [CrossRef]
  • 36. Anderson R, Oosthuizen R, Maritz R, Theron A, Van Rensburg AJ. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers. Am J Clin Nutr 1980; 33: 71-6.
  • 37. O’Toole P, Lombard M. Vitamin C and gastric cancer: supplements for some or fruit for all? Gut 1996; 39: 345-7. [CrossRef]
  • 38. Sezikli M, Cetinkaya ZA, Güzelbulut F, et al. Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with lowantioxidant capacity. Clin Res Hepatol Gastroenterol 2011; 35: 745-9. [CrossRef]
  • 39. Chuang CH, Sheu BS, Huan AH, et al. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce eradication rate of metronidazole-susceptible for Helicobacter pylori infection. Helicobacter 2002; 7: 310-6. [CrossRef]
  • 40. Kaboli SA, Zojaji H, Mirasattari D, et al. Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazole triple regimen on forHelicobacter pylori eradication. Acta Gastroenterol Belg 2009; 72: 222-4.
  • 41. Koçkar C, Oztürk M, Bavbek N. Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta Medica (Hradec Kralove) 2001; 44: 97-100.
  • 42. Chuang CH, Sheu BS, Kao AW, et al. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepatogastroenterology 2007; 54: 320-4.
APA Demirci H, UYGUN İLİKHAN S, ÖZTÜRK K, üstündağ y, KURT Ö, bilici m, KÖKTÜRK F, Uygun A (2015). Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. , 456 - 460.
Chicago Demirci Hakan,UYGUN İLİKHAN Sevil,ÖZTÜRK Kadir,üstündağ yücel,KURT Ömer,bilici muammer,KÖKTÜRK Fürüzan,Uygun Ahmet Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. (2015): 456 - 460.
MLA Demirci Hakan,UYGUN İLİKHAN Sevil,ÖZTÜRK Kadir,üstündağ yücel,KURT Ömer,bilici muammer,KÖKTÜRK Fürüzan,Uygun Ahmet Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. , 2015, ss.456 - 460.
AMA Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. . 2015; 456 - 460.
Vancouver Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. . 2015; 456 - 460.
IEEE Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A "Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection." , ss.456 - 460, 2015.
ISNAD Demirci, Hakan vd. "Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection". (2015), 456-460.
APA Demirci H, UYGUN İLİKHAN S, ÖZTÜRK K, üstündağ y, KURT Ö, bilici m, KÖKTÜRK F, Uygun A (2015). Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. Turkish Journal of Gastroenterology, 26(6), 456 - 460.
Chicago Demirci Hakan,UYGUN İLİKHAN Sevil,ÖZTÜRK Kadir,üstündağ yücel,KURT Ömer,bilici muammer,KÖKTÜRK Fürüzan,Uygun Ahmet Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. Turkish Journal of Gastroenterology 26, no.6 (2015): 456 - 460.
MLA Demirci Hakan,UYGUN İLİKHAN Sevil,ÖZTÜRK Kadir,üstündağ yücel,KURT Ömer,bilici muammer,KÖKTÜRK Fürüzan,Uygun Ahmet Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. Turkish Journal of Gastroenterology, vol.26, no.6, 2015, ss.456 - 460.
AMA Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. Turkish Journal of Gastroenterology. 2015; 26(6): 456 - 460.
Vancouver Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection. Turkish Journal of Gastroenterology. 2015; 26(6): 456 - 460.
IEEE Demirci H,UYGUN İLİKHAN S,ÖZTÜRK K,üstündağ y,KURT Ö,bilici m,KÖKTÜRK F,Uygun A "Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection." Turkish Journal of Gastroenterology, 26, ss.456 - 460, 2015.
ISNAD Demirci, Hakan vd. "Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection". Turkish Journal of Gastroenterology 26/6 (2015), 456-460.